期刊文献+

Induction of apoptosis by artemisinin relieving the severity of inflammation in caerulein-induced acute pancreatitis 被引量:14

Induction of apoptosis by artemisinin relieving the severity of inflammation in caerulein-induced acute pancreatitis
下载PDF
导出
摘要 AIM: To observe the apoptosis and oncosis of pancreatic acinar cells and secondary inflammatory reaction in pancreatic tissue from rats with acute pancreatitis (AP), and the influences of artemisinin on them.METHODS: AP was induced by 4 intraperitoneal iojections of caerulein at 1 h intervals. To induce apoptosis, solution of artemisinin (50 mg/kg) was given intraperitoneally 1, 12, 24 and 36 h after the last caerulein injection. Histological examination of impairment of pancreatic tissue and detection of serum amylase were performed to evaluate the severity of acute pancreatitis. Apoptosis and oncosis were detected with acridine orange (AO) and ethylene dibromide (EB) staining. Caspase-3 and myeloperoxidase (MPO) activity were measured by colorimetric assay. Nuclear factor-kappa B (NF-KB) activation was detected by flow cytometry. Macrophage inflammatory protein-lα(MIP-1α) protein was measured by Western blot. Interleukin- 1β(IL-1β) mRNA was detected by RT-PCR.RESULTS: Addition of artemisinin increased the number of apoptotic cells (11.7%±1.4% vs 6.3%± 0.7%, P 〈 0.05), while reduced the number of oncotic cells (13.0% ±2.4% vs 17.5%±2.2%, P 〈 0.05). The activity of caspase-3 speeded up (1.52±0.21 vs 1.03±0.08, P 〈 0.05), the pancreas pathological impairment was relieved (3.0±0.5 vs 4.0± 0.5, P 〈 0.05) and the level of serum amylase decreased (5642±721 U/dL vs 7821±653 U/dL, P 〈 0.05). The activation of NF-1α (29%±4.1% vs 42%±5.8%), MIP-1α protein (3.7±0.5 vs 5.8±0.7),MPO (0.52±0.06 U/g vs 0.68±0.09 U/g), IL-1β mRNA (1.7 ±0.3 vs 2.4 ±0.4) in the apoptosis inducing group was obviously decreased (P 〈 0.05).CONCLUSION: Inducing apoptosis can relieve pathological impairment and inflammatory reaction in AP rats. AIM:To observe the apoptosis and oncosis of pancreatic acinar cells and secondary inflammatory reaction in pancreatic tissue from rats with acute pancreatitis(AP),and the influences of artemisinin on them.METHODS:AP was induced by 4 intraperitoneal injections of caerulein at 1 h intervals.To induce apoptosis,solution of artemisinin(50 mg/kg)was given intraperitoneally 1,12,24 and 36 h after the last caerulein injection.Histological examination of impairment of pancreatic tissue and detection of serum amylase were performed to evaluate the severity of acute pancreatitis.Apoptosis and oncosis were detected with acridine orange(AO)and ethylene dibromide(EB)staining.Caspase-3 and myeloperoxidase(MPO)activity were measured by colorimetric assay.Nuclear factor-kappa B(NF-κB)activation was detected by flow cytometry.Macrophage inflammatory protein-1α(MIP-1α)protein was measured by Western blot.Interleukin-1β(IL-1β)mRNA was detected by RT-PCR.RESULTS:Addition of artemisinin increased the number of apoptotic cells(11.7% ± 1.4% vs 6.3% ± 0.7%,P < 0.05),while reduced the number of oncotic cells(13.0% ± 2.4% vs 17.5% ± 2.2%,P < 0.05).The activity of caspase-3 speeded up(1.52 ± 0.21 vs 1.03 ± 0.08,P < 0.05),the pancreas pathological impairment was relieved(3.0 ± 0.5 vs 4.0 ± 0.5,P < 0.05)and the level of serum amylase decreased(5642 ± 721 U/dL vs 7821 ± 653 U/dL,P < 0.05).The activation of NF-κB(29% ± 4.1% vs 42% ± 5.8%),MIP-1α protein(3.7 ± 0.5 vs 5.8 ± 0.7),MPO(0.52 ± 0.06 U/g vs 0.68 ± 0.09 U/g),IL-1β mRNA(1.7 ± 0.3 vs 2.4 ± 0.4)in the apoptosis inducing group was obviously decreased(P < 0.05).CONCLUSION:Inducing apoptosis can relieve pathological impairment and inflammatory reaction in AP rats.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第42期5612-5617,共6页 世界胃肠病学杂志(英文版)
基金 the Natural Science Foundation of Heilongjiang Province,China,No. D0227
关键词 PANCREATITIS APOPTOSIS Inflammation mediators CHEMOKINES ARTEMISININ 急性胰腺炎 炎症 细胞凋亡 发病机理
  • 相关文献

参考文献1

二级参考文献19

  • 1[13]Ricote M,Li AC,Willson TM,Kelly CJ,Glass CK.The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation.Nature 1998;391:79-82
  • 2[14]Shiojiri T,Wada K,Nakajima A,Katayama K,Shibuya A,Kudo C,Kadowaki T,Mayumi T,Yura Y,Kamisaki Y.PPAR gamma ligands inhibit nitrotyrosine formation and inflammatory mediator expressions in adjuvant-induced rheumatoid arthritis mice.Eur J Pharmacol 2002;448:231-238
  • 3[15]He ZJ,Winston JH,Yusuf TE,Micci MA,Elfert A,Xiao SY,Pasricha PJ.Intraductal administration of an NK1 receptor antagonist attenuates the inflammatory response to retrograde infusion of radiological contrast in rats:implications for the pathogenesis and prevention of ERCP-induced pancreatitis.Pancreas 2003;27:e13-e17
  • 4[16]Trush MA,Egner PA,Kensler TW.Myeloperoxidase as a biomarker of skin irritation and inflammation.Food Chem Toxicol 1994;32:143-147
  • 5[17]Sanchez-Hidalgo M,Martin AR,Villegas I,Alarcon De La Lastra C.Rosiglitazone,an agonist of peroxisome proliferatoractivated receptor gamma,reduces chronic colonic inflammation in rats.Biochem Pharmacol 2005;69:1733-1744
  • 6[18]Zafiriou S,Stanners SR,Saad S,Polhill TS,Poronnik P,Pollock CA.Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts.J Am Soc Nephrol 2005;16:638-645
  • 7[19]Vaquero E,Gukovsky I,Zaninovic V,Gukovskaya AS,Pandol SJ.Localized pancreatic NF-kappaB activation and inflammatory response in taurocholate-induced pancreatitis.Am J Physiol Gastrointest Liver Physiol 2001;280:G1197-G1208
  • 8[1]Barthet M,Lesavre N,Desjeux A,Gasmi M,Berthezene P,Berdah S,Viviand X,Grimaud JC.Complications of endoscopic sphincterotomy:results from a single tertiary referral center.Endoscopy 2002;34:991-997
  • 9[2]Freeman ML,DiSario JA,Nelson DB,Fennerty MB,Lee JG,Bjorkman DJ,Overby CS,Aas J,Ryan ME,Bochna GS,Shaw MJ,Snady HW,Erickson RV,Moore JP,Roel JP.Risk factors for post-ERCP pancreatitis:a prospective,multicenter study.Gastrointest Endosc 2001;54:425-434
  • 10[3]Andriulli A,Leandro G,Niro G,Mangia A,Festa V,Gambassi G,Villani MR,Facciorusso D,Conoscitore P,Spirito F,De Maio G.Pharmacologic treatment can prevent pancreatic injury after ERCP:a meta-analysis.Gastrointest Endosc 2000;51:1-7

共引文献5

同被引文献115

引证文献14

二级引证文献94

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部